Proteoglycan-4 Predicts Good Prognosis in Patients with Hepatocellular Carcinoma Receiving Transcatheter Arterial Chemoembolization and Inhibits Cancer Cell Migration

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Nov 28

PMID 36439456

Authors

Yuan Guo

Hong Tao Hu

Shi Jun Xu

Wei Li Xia

Yan Zhao

Xiao Hui Zhao

Wen Bo Zhu

Fang Ting Li

Hai Liang Li

Affiliations

Soon will be listed here.

Abstract

Purpose: To search for adaptive response molecules that affect the efficacy of transcatheter arterial chemoembolization (TACE), analyze their clinical correlation with and prognostic value for hepatocellular carcinoma (HCC), and explore their impact on cell biological behavior and their mechanisms of action.

Methods: HCC tissue gene sequencing was used to identify differentially expressed genes. The expression of proteoglycan 4 (PRG4) in the serum of 117 patients with HCC who received TACE was detected by enzyme-linked immunosorbent assay. Serum-free medium mimicked TACE-induced nutrient deprivation. Cells with stable knockdown of PRG4 (shPRG4) were constructed to verify the effect and mechanism of PRG4 on the biological behavior of HCC cells .

Results: The expression of PRG4 was significantly elevated under TACE-induced starvation conditions. Low PRG4 expression was associated with worse response to TACE treatment, shorter survival time, and stronger HCC migration ability. Furthermore, experiments showed that knockdown of PRG4 promoted HCC cell migration by enhancing epithelial-mesenchymal transition (EMT) while did not affect proliferation. When PRG4 expression was low, starvation treatment impaired the migratory ability of HCC cells and reduced the chemosensitivity of HCC cells to epirubicin.

Conclusions: PRG4 expression predicts survival and TACE treatment response in patients with HCC. Furthermore, knockdown of PRG4 enhanced EMT, leading to HCC cell migration. PRG4 may serve as a biomarker for HCC patients receiving TACE.

Citing Articles

Immune effect and prognosis of transcatheter arterial chemoembolization and tyrosine kinase inhibitors therapy in patients with hepatocellular carcinoma.

Guo Y, Li R, Xia W, Yang X, Zhu W, Li F World J Gastrointest Oncol. 2024; 16(7):3256-3269.

PMID: 39072154 PMC: 11271774. DOI: 10.4251/wjgo.v16.i7.3256.

Proteomic profiling of extracellular vesicles derived from human serum for the discovery of biomarkers in Avascular necrosis.

Sung S, Lim J, Kang K, Choi J, Lee S, Sung M Clin Proteomics. 2024; 21(1):39.

PMID: 38825675 PMC: 11145856. DOI: 10.1186/s12014-024-09489-2.

Hawthorn Proanthocyanidin Extract Inhibits Colorectal Carcinoma Metastasis by Targeting the Epithelial-Mesenchymal Transition Process and Wnt/β-Catenin Signaling Pathway.

Wang Z, Sun Y, Wu M, Zhou L, Zheng Y, Ren T Foods. 2024; 13(8).

PMID: 38672844 PMC: 11049232. DOI: 10.3390/foods13081171.

Redlining-associated methylation in breast tumors: the impact of contemporary structural racism on the tumor epigenome.

Miller-Kleinhenz J, Moubadder L, Beyer K, Zhou Y, Gaglioti A, Collin L Front Oncol. 2023; 13:1154554.

PMID: 37621676 PMC: 10446968. DOI: 10.3389/fonc.2023.1154554.

References

Sarkar A, Chanda A, Regmi S, Karve K, Deng L, Jay G . Recombinant human PRG4 (rhPRG4) suppresses breast cancer cell invasion by inhibiting TGFβ-Hyaluronan-CD44 signalling pathway. PLoS One. 2019; 14(7):e0219697. PMC: 6667139. DOI: 10.1371/journal.pone.0219697. View

Al-Sharif A, Jamal M, Zhang L, Larson K, Schmidt T, Jay G . Lubricin/Proteoglycan 4 Binding to CD44 Receptor: A Mechanism of the Suppression of Proinflammatory Cytokine-Induced Synoviocyte Proliferation by Lubricin. Arthritis Rheumatol. 2015; 67(6):1503-13. PMC: 4446227. DOI: 10.1002/art.39087. View

Onrust S, Wiseman L, Goa K . Epirubicin: a review of its intravesical use in superficial bladder cancer. Drugs Aging. 1999; 15(4):307-33. DOI: 10.2165/00002512-199915040-00006. View

Alquraini A, Jamal M, Zhang L, Schmidt T, Jay G, Elsaid K . The autocrine role of proteoglycan-4 (PRG4) in modulating osteoarthritic synoviocyte proliferation and expression of matrix degrading enzymes. Arthritis Res Ther. 2017; 19(1):89. PMC: 5423025. DOI: 10.1186/s13075-017-1301-5. View

Dituri F, Mancarella S, Cigliano A, Chieti A, Giannelli G . TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives. Semin Liver Dis. 2018; 39(1):53-69. DOI: 10.1055/s-0038-1676121. View

Zhai X, Chen Z, Li B, Shen F, Fan J, Zhou W . Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial. J Integr Med. 2013; 11(2):90-100. DOI: 10.3736/jintegrmed2013021. View

Wehling C, Dill M, Olkus A, Springfeld C, Chang D, Naumann P . Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities. J Cancer Res Clin Oncol. 2021; 147(8):2471-2481. PMC: 8236446. DOI: 10.1007/s00432-021-03528-3. View

Jay G, Waller K . The biology of lubricin: near frictionless joint motion. Matrix Biol. 2014; 39:17-24. DOI: 10.1016/j.matbio.2014.08.008. View

Jemal A, Ward E, Johnson C, Cronin K, Ma J, Ryerson B . Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival. J Natl Cancer Inst. 2017; 109(9). PMC: 5409140. DOI: 10.1093/jnci/djx030. View

10.

Wu X, Xie G, Chen D . Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma. J Gastroenterol Hepatol. 2007; 22(8):1178-82. DOI: 10.1111/j.1440-1746.2007.04997.x. View

11.

Dituri F, Scialpi R, Schmidt T, Frusciante M, Mancarella S, Lupo L . Proteoglycan-4 is correlated with longer survival in HCC patients and enhances sorafenib and regorafenib effectiveness via CD44 in vitro. Cell Death Dis. 2020; 11(11):984. PMC: 7669886. DOI: 10.1038/s41419-020-03180-8. View

12.

Reichert M, Massmann A, Schulz A, Buecker A, Glanemann M, Lammert F . Volume-Function Analysis (LiMAx Test) in Patients with HCC and Cirrhosis Undergoing TACE-A Feasibility Study. Dig Dis Sci. 2020; 66(7):2452-2460. PMC: 8236026. DOI: 10.1007/s10620-020-06535-5. View

13.

Artiach G, Carracedo M, Seime T, Plunde O, Laguna-Fernandez A, Matic L . Proteoglycan 4 is Increased in Human Calcified Aortic Valves and Enhances Valvular Interstitial Cell Calcification. Cells. 2020; 9(3). PMC: 7140654. DOI: 10.3390/cells9030684. View

14.

Lambiase A, Sullivan B, Schmidt T, Sullivan D, Jay G, Truitt 3rd E . A Two-Week, Randomized, Double-masked Study to Evaluate Safety and Efficacy of Lubricin (150 μg/mL) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops (Vismed®) in Patients with Moderate Dry Eye Disease. Ocul Surf. 2016; 15(1):77-87. DOI: 10.1016/j.jtos.2016.08.004. View

15.

Piscaglia F, Ogasawara S . Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment. Liver Cancer. 2018; 7(1):104-119. PMC: 5892363. DOI: 10.1159/000485471. View

16.

Martin R, Geller D, Espat J, Kooby D, Sellars M, Goldstein R . Safety and efficacy of trans arterial chemoembolization with drug-eluting beads in hepatocellular cancer: a systematic review. Hepatogastroenterology. 2012; 59(113):255-60. DOI: 10.5754/hge10240. View

17.

Li J, Liang Q, Sun G . Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. J Integr Med. 2021; 19(6):469-477. DOI: 10.1016/j.joim.2021.08.004. View

18.

Marrero J, Kulik L, Sirlin C, Zhu A, Finn R, Abecassis M . Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018; 68(2):723-750. DOI: 10.1002/hep.29913. View

19.

Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T . The role of autophagy during the early neonatal starvation period. Nature. 2004; 432(7020):1032-6. DOI: 10.1038/nature03029. View

20.

Zhang G, Zhang G . Upregulation of FoxP4 in HCC promotes migration and invasion through regulation of EMT. Oncol Lett. 2019; 17(4):3944-3951. PMC: 6425392. DOI: 10.3892/ol.2019.10049. View